fbpx
  1. Home
  2. »
  3. Pandemic Pulse
  4. »
  5. Daily Research Pulse
  6. »
  7. Daily Research Pulse for January 21, 2023

Daily Research Pulse for January 21, 2023

Facebook
Twitter
LinkedIn
Print
Summary: One study aims to assess the incidence of RSV-positive ARI before and during the COVID-19 pandemic, and to assess outcomes for RSV-positive ARI in older adults.

Daily News Pulse for January 29, 2023

Summary: Governor John Carney has tested positive for COVID-19 and is working from home. The 7-day average of new cases in Delaware is 135, with 158 hospitalizations. A new study has found that 71% of people with long COVID required medical treatment or were unable to work for six months or more. The FDA has withdrawn emergency use authorization for the COVID-19 antibody drug Evusheld due to its ineffectiveness against the Omicron variants now dominating the US.

Daily Research Pulse for January 29, 2023

Summary: One study analyzed the frequency of influenza and SARS-CoV-2 co-infections, as well as the differences in the course of disease in patients infected with the SARS-CoV-2 virus in relation to flu vaccination status in a cohort of 19,850 patients diagnosed with COVID-19 in Spain.

Daily News Pulse for January 28, 2023

Summary: Scientists have found that 36% of students and faculty at George Washington University have a history of COVID-19 reported symptoms consistent with long COVID. Vaccinations may be linked to lower post-COVID-19 risk factors, but more research is needed. A new study from INSPIRE found that half of COVID-positive patients and one-quarter of those who tested negative had at least one symptom at three months follow-up.

Daily Research Pulse for January 28, 2023

Summary: One study examined the impact of COVID-19 on access to general practice care in Ireland by conducting an online survey of 670 adult patients of Irish general practices. Another study looked at the effectiveness of the mRNA COVID-19 vaccine among urban underserved Hispanic/Latino populations.

Daily News Pulse for January 27, 2023

Summary: The FDA has voted to update all Covid-19 vaccines to contain the same ingredients as the two-strain shots used as booster doses. Studies have shown that the SARS-CoV-2 spike protein can cross the blood-brain barrier, leading to cognitive impairment and inflammation. CDC data shows that COVID cases, deaths, and hospitalizations have stabilized after a small surge around the holidays, but there is still uncertainty about long COVID.